<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396810</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00028376 D14236</org_study_id>
    <nct_id>NCT02396810</nct_id>
  </id_info>
  <brief_title>Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <brief_summary>
    <textblock>
      The investigators are studying the utility of intra-operative magnetic resonance imaging
      (iMRI) during transsphenoidal pituitary surgery by randomizing patients to either an
      intra-operative MRI after resection, or no intra-operative MRI. The investigators will then
      count the number of gross total resection in each group of patients and also the
      complications related to surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gross total resection</measure>
    <time_frame>24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endocrine function, specifically serum levels of TSH, morning cortisol, sodium, somatomedin, FH, LSH, and documented need for desmopressin</measure>
    <time_frame>30 days post-op</time_frame>
    <description>TSH level, morning cortisol level, documented need for desmopressin, sodium level, somatomedin level, FH level, LSH level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CSF leak</measure>
    <time_frame>30 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>30 days post-op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Pituitary Macroadenoma</condition>
  <arm_group>
    <arm_group_label>No intra-operative MRI</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients undergo transsphenoidal surgery without an intra-operative MRI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intra-operative MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo transspheonidal surgery followed by intra-operative MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intra-operative MRI</intervention_name>
    <description>Intra-operative magnetic resonance imaging under general anesthesia</description>
    <arm_group_label>intra-operative MRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transsphenoidal resection of pituitary macroadenoma</intervention_name>
    <description>Routine transsphenoidal resection of pituitary macro adenomas</description>
    <arm_group_label>No intra-operative MRI</arm_group_label>
    <arm_group_label>intra-operative MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults 18-90

          -  Pituitary macroadenoma in MRI

          -  Elect for transsphenoidal surgery

        Exclusion Criteria:

          -  Children (age &lt; 18)

          -  Pituitary macroadenoma

          -  Unable to tolerate MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nathan E Simmons, MD</last_name>
    <phone>603 650 5109</phone>
    <email>nathan.e.simmons@hitchcock.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03765</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan E Simmons, MD</last_name>
      <phone>603-650-5109</phone>
      <email>nathan.e.simmons@hithcock.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Hong, MD</last_name>
      <phone>603 650 5109</phone>
      <email>j.hong7@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nathan E Simmons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Hong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Nathan E. Simmons</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pituitary Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

